ADRD Research Leader - Associate Professor

Icahn School of Medicine at Mount Sinai; New York (NY); Presencial; USD 250.000 - 450.000; Jornada completa

Descripción de la vacante

The Icahn School of Medicine at Mount Sinai (ISMMS) and the Mount Sinai Health System invite applications for an Associate Professor or Professor level position in Alzheimer’s disease and related dementias (ADRD). The successful candidate will be a clinician-scientist or physician-scientist with an internationally recognized NIH-funded research program and a strong record of leadership.

We seek a nationally recognized leader who will help shape ADRD research, clinical innovation, and precision

Formación

• Established clinical research program with national reputation in ADRD.
• Sustained NIH funding and scholarly achievement in Alzheimer's disease and related dementias.
• Leadership, mentorship, and multidisciplinary collaboration demonstrated at scale.

Responsabilidades

• Maintain and expand an externally funded research program.
• Foster multidisciplinary collaborations across Mount Sinai's institutes and health system.
• Lead within Mount Sinai’s Alzheimer’s Disease Research Center and affiliated programs.
• Contribute to strategic growth of ADRD programs.
• Educate and mentor medical students, residents, and fellows.
• Provide outstanding clinical care to individuals living with ADRD where clinically trained.

Conocimientos

NIH funding

Clinical investigator

Mentorship

Multidisciplinary collaboration

Program leadership

Educación

MD/PhD

Board cert in Neurology/Psych

Clinical/research fellowship

Descripción del empleo

The Icahn School of Medicine at Mount Sinai (ISMMS) and the Mount Sinai Health System invite applications for an Associate Professor or Professor level position in Alzheimer’s disease and related dementias (ADRD). The successful candidate will be a clinician-scientist or physician-scientist with an internationally recognized NIH-funded research program and a strong record of leadership.

We seek a nationally recognized leader who will help shape ADRD research, clinical innovation, and precision